Comparative Analysis and Benchmarking: Corporate Strategy Analysis of Four International Pharmaceutical Companies

Front Cover
Universal-Publishers, 2003 - Business & Economics - 140 pages
0 Reviews
This research of corporate strategy analysis implements comparative analysis and benchmarking to analyse and examine the corporate strategy of the pharmaceutical sectors of 4 international pharmaceutical companies. This research adopts the hybrid approach of combining qualitative and quantitative methods in a two stages research design. Quantitative method is applied first to deal with the comparative figures, and then qualitative method is used to find out the problem. The design of this multiple research includes three phases: data collection, analysis, and reporting. The findings of this research can be divided into 4 parts: R&D/marketing, technology alliances, strategic acquisitions and merger, and manufacturing. The drug innovative projects are recommended being developed within the company's familiar therapeutic areas in order to take its marketing advantage. Through this comparative analysis, some of this type of problems of these international pharmaceutical companies is identified. A big pharmaceutical company forming alliances with some small biotechnology companies has become a trend within pharmaceutical industry since 1980s. For pharmaceutical companies, to take advantage of R&D through biotechnology is the main purpose of alliances with small biotechnology companies. It is important to note that most pharmaceutical acquisitions belong to the type of absorption with high resource transferring and low autonomy. Due to the high profit margin and the essential importance of R&D and marketing, the operation management of manufacturing of pharmaceutical industry is relatively poor. The low asset utilisation rate pointed out this problem. Academic researches have revealed that existing theories of operation management of manufacturing, such as action research, set-up reduction, teamwork, continuous improvement, collaboration, and involvement, are applicable and beneficial to pharmaceutical industry rather than waiting for the technology breakthroughs.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

VIII
2
IX
5
X
9
XI
10
XII
11
XIII
13
XIV
15
XV
16
XXX
44
XXXI
45
XXXII
46
XXXIII
48
XXXIV
56
XXXV
59
XXXVI
85
XXXVII
86

XVI
17
XVII
18
XVIII
21
XIX
25
XX
26
XXI
27
XXII
32
XXIII
37
XXIV
38
XXV
39
XXVI
40
XXVIII
41
XXIX
42
XXXVIII
87
XXXIX
92
XL
99
XLI
100
XLII
101
XLIII
106
XLIV
110
XLV
113
XLVI
114
XLVII
115
XLVIII
125
Copyright

Common terms and phrases

Popular passages

Page ii - has been submitted in support of an application for another degree or qualification

Bibliographic information